% | $
Quotes you view appear here for quick access.

PROLOR Biotech, Inc. Message Board

  • kinsp45 kinsp45 Jun 20, 2012 10:07 AM Flag

    Value at these levels

    Seekin Alpha had two really good articles recently about Prolor
    Danish drug giant Novo Nordisk (NVO) is currently in phase III trials with Liraglutide, an application based on a naturally occurring human peptide that's delivered in the form of a once-daily injection. The company currently has the lion's share of the market, but could soon be overtaken by Prolor Biotech (PBTH), which is developing a once-weekly version of Novo Nordisk's protein therapy. Prolor's breakthrough would make administration far more feasible and therefore poses a greater threat to those developers currently ahead in the race.

    Prolor Biotech is an Israel-based company that has products that are going through the FDA approval process that aim to provide a more user-friendly version of existing Human Growth Hormone treatment. The main axe on this name is Summer Street Research Partners. Their latest DCF model points to a price target of $8 per share. The current stock price reflects a 32% discount from the true equity value

    SortNewest  |  Oldest  |  Most Replied Expand all replies